- Home
- VRA vs STTK Comparison
VRA vs STTK Comparison
Compare VRA & STTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VRA
- STTK
- Stock Information
- Founded
- VRA 1982
- STTK 2016
- Country
- VRA United States
- STTK United States
- Employees
- VRA N/A
- STTK N/A
- Industry
- VRA Apparel
- STTK Biotechnology: Pharmaceutical Preparations
- Sector
- VRA Consumer Discretionary
- STTK Health Care
- Exchange
- VRA Nasdaq
- STTK Nasdaq
- Market Cap
- VRA 102.9M
- STTK 56.8M
- IPO Year
- VRA 2010
- STTK 2020
- Fundamental
- Price
- VRA $3.72
- STTK $1.12
- Analyst Decision
- VRA Strong Buy
- STTK Hold
- Analyst Count
- VRA 1
- STTK 3
- Target Price
- VRA $5.50
- STTK $2.00
- AVG Volume (30 Days)
- VRA 363.1K
- STTK 182.2K
- Earning Date
- VRA 12-11-2024
- STTK 02-27-2025
- Dividend Yield
- VRA N/A
- STTK N/A
- EPS Growth
- VRA N/A
- STTK N/A
- EPS
- VRA N/A
- STTK N/A
- Revenue
- VRA $405,268,000.00
- STTK $6,435,000.00
- Revenue This Year
- VRA N/A
- STTK $313.04
- Revenue Next Year
- VRA $4.90
- STTK N/A
- P/E Ratio
- VRA N/A
- STTK N/A
- Revenue Growth
- VRA N/A
- STTK 382.75
- 52 Week Low
- VRA $3.27
- STTK $0.94
- 52 Week High
- VRA $8.32
- STTK $11.76
- Technical
- Relative Strength Index (RSI)
- VRA 40.52
- STTK 43.75
- Support Level
- VRA $3.46
- STTK $1.13
- Resistance Level
- VRA $3.97
- STTK $1.39
- Average True Range (ATR)
- VRA 0.22
- STTK 0.11
- MACD
- VRA 0.05
- STTK 0.00
- Stochastic Oscillator
- VRA 54.88
- STTK 18.18
About VRA Vera Bradley Inc.
Vera Bradley Inc designs women's handbags, travel items, and accessories. Each category comprises a substantial component of total sales, with the bags category comprising the most. most of the company's sales are made directly to customers through Vera Bradley's retail stores and e-commerce sites. The company also has a substantial wholesale business selling to specialty retail and department stores. Almost all company sales are in the United States. Vera Bradley uses third-party manufacturers in Asia to produce its products, and the company distributes the products through its distribution center in Indiana. The Company has three reportable segments: Vera Bradley Direct, Vera Bradley Indirect, and Pura Vida. The majority of revenue is from the Vera Bradley Direct segment.
About STTK Shattuck Labs Inc.
Shattuck Labs Inc is a clinical-stage biotechnology company pioneering the development of dual-sided fusion proteins as an entirely new class of biologic medicine. Its product candidate, SL-172154, has been rationally designed to simultaneously inhibit the CD47/SIRPa checkpoint interaction to restore an anti-tumor immune response and to activate the CD40 costimulatory receptor to bolster an immune response. Its product candidate, SL-279252, which is being developed in collaboration with Takeda Pharmaceuticals, or Takeda, has been rationally designed to simultaneously inhibit the PD-1/PD-L1 interaction and activate the OX40 receptor.